Overview of Mpox Outbreak in the US
The horror of mpox has returned to scare the US with more than 570 cases detected so far in 2024, doubling from the previous year.
Infection Rate Comparison
The current infection rate is lower than the peak in August 2022, when the US saw an average of about 470 new cases per week.
Mpox Vaccination Information
- JYNNEOS is the primary mpox vaccine in the US, given in two doses a month apart.
- Full immunization is achieved two weeks after the second dose, with no current recommendation for booster shots.
- Eligibility and vaccination site information can be found on the CDC website and local health department sites.
Mpox Virus Details
Mpox, formerly known as monkeypox, is caused by a virus related to the variola virus.
- Mpox viruses are categorized into clade I and clade II, with clade I posing a higher risk of fatal disease.
- JYNNEOS vaccine provides protection against both clades.
Symptoms and Spread of Mpox
Mpox can present flu-like symptoms and characteristic pox rashes, with varying severity based on the individual’s immune system.
The disease primarily spreads through close contact with infected individuals.
Current Mpox Cases in the US
Over 30,000 cases have been reported since the outbreak began in May 2022, with infection rates increasing in 2024 compared to 2023.
States like New York City, California, and Florida have reported significant numbers of cases.
The Virginia Department of Health noted an increase in cases in 2024 compared to the previous year.
